| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absorption, distribution, metabolism, and excretion (ADME) of 14C-sonidegib (LDE225) in healthy volunteers
|
Zollinger, Markus
|
|
2014
|
74 |
1 |
p. 63-75
|
artikel
|
| 2 |
Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories
|
Cheng, Lei
|
|
2014
|
74 |
1 |
p. 1-13
|
artikel
|
| 3 |
A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors
|
Wakui, Hiroshi
|
|
2014
|
74 |
1 |
p. 15-23
|
artikel
|
| 4 |
A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors
|
Wakui, Hiroshi
|
|
|
74 |
1 |
p. 15-23
|
artikel
|
| 5 |
A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer
|
Roxburgh, Patricia
|
|
2014
|
74 |
1 |
p. 131-139
|
artikel
|
| 6 |
A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors
|
McRee, Autumn J.
|
|
2014
|
74 |
1 |
p. 117-123
|
artikel
|
| 7 |
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
|
Horinouchi, Hidehito
|
|
2014
|
74 |
1 |
p. 37-43
|
artikel
|
| 8 |
Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells
|
Min, Han
|
|
2014
|
74 |
1 |
p. 167-176
|
artikel
|
| 9 |
Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
|
Rodrigueza, Wendi V.
|
|
2014
|
74 |
1 |
p. 151-166
|
artikel
|
| 10 |
High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin
|
Arrieta, Oscar
|
|
2014
|
74 |
1 |
p. 211-215
|
artikel
|
| 11 |
Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)
|
Pillai, Rathi N.
|
|
2014
|
74 |
1 |
p. 177-183
|
artikel
|
| 12 |
Irinotecan and temozolomide brain distribution: a focus on ABCB1
|
Goldwirt, Lauriane
|
|
2014
|
74 |
1 |
p. 185-193
|
artikel
|
| 13 |
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors
|
Mita, Monica
|
|
2014
|
74 |
1 |
p. 195-204
|
artikel
|
| 14 |
Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer
|
Jiang, Yixing
|
|
2014
|
74 |
1 |
p. 205-210
|
artikel
|
| 15 |
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer
|
Jary, Marine
|
|
2014
|
74 |
1 |
p. 141-150
|
artikel
|
| 16 |
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma
|
Mahalingam, Devalingam
|
|
2014
|
74 |
1 |
p. 77-84
|
artikel
|
| 17 |
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
|
Bendell, Johanna C.
|
|
2014
|
74 |
1 |
p. 125-130
|
artikel
|
| 18 |
Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia
|
Golabchifar, Ali-Akbar
|
|
2014
|
74 |
1 |
p. 85-93
|
artikel
|
| 19 |
Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
|
Gu, Yi
|
|
2014
|
74 |
1 |
p. 95-115
|
artikel
|
| 20 |
Protracted dosing of the lipophilic camptothecin analogue AR-67 in non-small cell lung cancer xenografts and humans
|
Tsakalozou, Eleftheria
|
|
2014
|
74 |
1 |
p. 45-54
|
artikel
|
| 21 |
Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib
|
Xiong, Hao
|
|
2014
|
74 |
1 |
p. 55-61
|
artikel
|
| 22 |
Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent
|
Chen, Ying Yi
|
|
2014
|
74 |
1 |
p. 25-35
|
artikel
|
Tijdschrift beschrijving